Zobrazeno 1 - 4
of 4
pro vyhledávání: '"G. Caleb Alexander"'
Autor:
Alexander R. Zheutlin, Nasser Sharareh, Jenny S. Guadamuz, Ransmond O. Berchie, Catherine G. Derington, Joshua A. Jacobs, Favel L. Mondesir, G. Caleb Alexander, Emily B. Levitan, Monika Safford, Robert O. Vos, Dima M. Qato, Adam P. Bress
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 5 (2024)
Background Poor neighborhood‐level access to health care, including community pharmacies, contributes to cardiovascular disparities in the United States. The authors quantified the association between pharmacy proximity, antihypertensive and statin
Externí odkaz:
https://doaj.org/article/b9b50bd1dca2489399c69580e1c71e23
Autor:
Rishav Adhikari, Kunal Jha, Zeina Dardari, James Heyward, Roger S. Blumenthal, Robert H. Eckel, G. Caleb Alexander, Michael J. Blaha
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 9 (2022)
Background Sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) mitigate cardiovascular risk in individuals with type 2 diabetes, but most eligible patients do not receive them. We cha
Externí odkaz:
https://doaj.org/article/54e819014e4549dc8a35d0dce0097b46
Autor:
Xiaoxi Yao, Neena S. Abraham, G. Caleb Alexander, William Crown, Victor M. Montori, Lindsey R. Sangaralingham, Bernard J. Gersh, Nilay D. Shah, Peter A. Noseworthy
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 2 (2016)
BackgroundIn comparison to warfarin, non–vitamin K antagonist oral anticoagulants (NOACs) have the advantages of ease of dosing, fewer drug interactions, and lack of need for ongoing monitoring. We sought to evaluate whether these advantages transl
Externí odkaz:
https://doaj.org/article/103c1875741242478c5c107b71d750f1
Autor:
Neena S. Abraham, Victor M. Montori, Peter A. Noseworthy, Nilay Shah, Lindsey R. Sangaralingham, Xiaoxi Yao, Bernard J. Gersh, G. Caleb Alexander, William H. Crown
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background In comparison to warfarin, non–vitamin K antagonist oral anticoagulants ( NOAC s) have the advantages of ease of dosing, fewer drug interactions, and lack of need for ongoing monitoring. We sought to evaluate whether these advantages tra